GO
Loading...

Eli Lilly and Co

More

  • Midday movers: NFLX, PCLN, BIIB & more Thursday, 15 May 2014 | 12:23 PM ET
    NYSE exchange floor

    Take a look at some of Thursday's midday movers:

  • SHANGHAI, May 15- GlaxoSmithKline Plc executive Mark Reilly had little inkling he would be charged with leading a network of corruption in China's pharmaceutical industry, two sources with ties to the businessman and knowledge of the investigation said.

  • Eli Lilly loses UK Alimta patent case to Actavis Thursday, 15 May 2014 | 7:07 AM ET

    LONDON, May 15- Eli Lilly said on Thursday it had lost a patent case in the English High Court over its blockbuster Alimta lung cancer drug to generic drugmaker Actavis.

  • SHANGHAI, May 15- GlaxoSmithKline Plc executive Mark Reilly had little inkling he would be charged with leading a network of corruption in China's pharmaceutical industry, two sources with ties to the businessman and knowledge of the investigation said.

  • This year, at ASCO, all eyes are on pharma Wednesday, 14 May 2014 | 3:41 PM ET

    Some stocks moved after the bell after abstracts for the American Society of Clinical Oncology meeting dropped Wednesday.

  • Your first trade for Wednesday Tuesday, 13 May 2014 | 1:36 PM ET

    The "Fast Money" traders share their final trades of the day.

  • Midday movers: Aaron's, Eli Lilly, Gogo & More Monday, 12 May 2014 | 12:30 PM ET
    NYSE EuroNext flag hangs outside the NYSE.

    Some of Monday's midday movers:

  • May 12- Eli Lilly and Co said its type 2 diabetes drug was more effective than Sanofi SA's approved drug Lantus in reducing patients' blood sugar levels in three late-stage trials. Sanofi's Lantus is the world's most prescribed insulin product with quarterly worldwide sales of about $2 billion. The drug will lose U.S. patent protection in February 2015.

  • May 12- Eli Lilly and Co said its type 2 diabetes treatment was as effective as Sanofi SA's approved drug Lantus in reducing patients' blood sugar levels in three late-stage trials.

  • FACTBOX-M&A frenzy transforming global pharma Tuesday, 6 May 2014 | 2:00 PM ET

    MAY May 6- Merck& Co Inc agrees to sell its consumer care business to Germany's Bayer AG for $14.2 billion. May 2- Pfizer Inc raises its offer for AstraZeneca Plc to 63 billion pounds, but the British company promptly rejects the proposal, which would create the world's biggest pharmaceuticals company.

  • *Sanofi looking to sell mature products with $3.7 bln sales. *Sanofi shares gain 1.5 percent. Shares in Sanofi rose 1.5 percent in early trade on Wednesday following the news.

  • FACTBOX-M&A frenzy in healthcare sector Tuesday, 29 Apr 2014 | 2:25 PM ET

    **U.S. drugmaker Pfizer said on April 28 that it had offered to buy Britain's AstraZeneca Plc in January for about $98.9 billion, or nearly 47 pounds per share.

  • *Mylan offering 145 SEK/ share for Sweden's Meda. NEW YORK/ STOCKHOLM, April 25- U.S. generic drugmaker Mylan has made a new and improved bid for Meda valuing its Swedish rival at around $9 billion including debt, a person familiar with the matter said on Friday.

  • Activists, big pharma & lil' 'Squawkers' deliver Thursday, 24 Apr 2014 | 7:02 PM ET

    What a week on "Squawk Box"! Bill Ackman teams up with Valeant to buy Botox-maker Allergan. Novartis' buying and selling and lil' Squawkers running the show.

  • April 24- Zimmer Holdings Inc said on Thursday it would buy rival orthopedic products maker Biomet Inc for more than $13 billion, the latest deal in a wave of consolidations in the healthcare industry. The deal is expected to take Zimmer from the fourth-largest seller of orthopedics products to No. 2, behind Johnson& Johnson.

  • Lilly's weak sales put focus on drug pipeline Thursday, 24 Apr 2014 | 10:30 AM ET

    U.S. drugmaker Eli Lilly reported lower-than-expected quarterly revenue as it was hurt by disappointing sales of its cancer and diabetes drugs.

  • April 24- Eli Lilly and Co reported lower-than-expected quarterly revenue on Thursday, hurt by disappointing sales of its cancer and diabetes drugs, and its shares fell more than 3 percent.

  • Wall Street seen higher after Apple, durable goods Thursday, 24 Apr 2014 | 8:18 AM ET

    U.S. stock index futures pushed higher on Thursday, as Apple and Facebook's strong earnings boosted early trade in Europe.

  • Early movers: GM, CAT, AMZN, UPS & more Thursday, 24 Apr 2014 | 8:07 AM ET
    Traders work the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • *Tech results lift Nasdaq futures, Apple and Facebook rally. *Attention on Apple after announcing seven-for-one stock split. NEW YORK, April 24- U.S. stock index futures were higher on Thursday, with Nasdaq futures jumping more than 1 percent following a pair of blowout results from technology stalwarts Apple and Facebook.